Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.

Grande E, Bellmunt J, Hussain SA, Al Mansour MM, Bamias A, Barthélémy P, Benjamin DJ, Blais N, Bourlon MT, Castellano D, Danchaivijitr P, Fernandez Lazzaro M, Giannatempo P, Guerrero-Ramos F, Iacovelli R, Ivanyi P, Jung EH, Kanesvaran R, Manneh R, Marinho JC, Matsubara N, Merseburger AS, Mukherji D, Park CH, Tran B, da Trindade KM, Ürün Y, Kamat AM, Birtle AJ

Open source

DOI: 10.1093/oncolo/oyaf333
Published: 2025 Oct 1
Container: The oncologist
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyaf333,
  title = {Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.},
  author = {Grande E and Bellmunt J and Hussain SA and Al Mansour MM and Bamias A and Barthélémy P and Benjamin DJ and Blais N and Bourlon MT and Castellano D and Danchaivijitr P and Fernandez Lazzaro M and Giannatempo P and Guerrero-Ramos F and Iacovelli R and Ivanyi P and Jung EH and Kanesvaran R and Manneh R and Marinho JC and Matsubara N and Merseburger AS and Mukherji D and Park CH and Tran B and da Trindade KM and Ürün Y and Kamat AM and Birtle AJ},
  year = {2025},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyaf333},
  url = {https://doi.org/10.1093/oncolo/oyaf333}
}

RIS

TY  - JOUR
TI  - Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.
AU  - Grande E
AU  - Bellmunt J
AU  - Hussain SA
AU  - Al Mansour MM
AU  - Bamias A
AU  - Barthélémy P
AU  - Benjamin DJ
AU  - Blais N
AU  - Bourlon MT
AU  - Castellano D
AU  - Danchaivijitr P
AU  - Fernandez Lazzaro M
AU  - Giannatempo P
AU  - Guerrero-Ramos F
AU  - Iacovelli R
AU  - Ivanyi P
AU  - Jung EH
AU  - Kanesvaran R
AU  - Manneh R
AU  - Marinho JC
AU  - Matsubara N
AU  - Merseburger AS
AU  - Mukherji D
AU  - Park CH
AU  - Tran B
AU  - da Trindade KM
AU  - Ürün Y
AU  - Kamat AM
AU  - Birtle AJ
PY  - 2025
JO  - The oncologist
DO  - 10.1093/oncolo/oyaf333
UR  - https://doi.org/10.1093/oncolo/oyaf333
ER  -

APA

E, G., J, B., SA, H., MM, A. M., A, B., P, B., DJ, B., N, B., MT, B., D, C., P, D., M, F. L., P, G., F, G., R, I., P, I., EH, J., R, K., R, M., JC, M., N, M., AS, M., D, M., CH, P., B, T., KM, D. T., Y, Ü., AM, K., & AJ, B. (2025). Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.. The oncologist. https://doi.org/10.1093/oncolo/oyaf333

Source records

pubmed · retrieved 2026-09-25T14:31:58.695Z